A prospective cohort study from the International Society for Infectious Diseases found COVID-19 exposure in-utero was associated with infant neurodevelopmental delay during the first year of life. Despite study limitations, these findings do note the significance of understanding the effects of maternal infection on infants so effective interventions are recommended and provided. Furthermore, precise guidance regarding follow-up care for these affected infants is necessary for reducing negative effects on long-term health.
With respiratory season in full swing, remember to talk with your pregnant and postpartum patients about the COVID-19 vaccine. Data demonstrate the COVID-19 vaccine is safe before, during, and after pregnancy.
View Cohort Study
View the CDC's recommendations regarding COVID-19 vaccines and pregnancy
Access patient-facing resources at the CDC Foundation's "Pregnant and Protected" Campaign
Comments